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ARTICLE
Characterization of Potocki-Lupski Syndrome
(dup(17)(p11.2p11.2)) and Delineation of a Dosage-Sensitive
Critical Interval That Can Convey an Autism Phenotype
Lorraine Potocki,* Weimin Bi,* Diane Treadwell-Deering, Claudia M. B. Carvalho, Anna Eifert,
Ellen M. Friedman, Daniel Glaze, Kevin Krull, Jennifer A. Lee, Richard Alan Lewis,
Roberto Mendoza-Londono, Patricia Robbins-Furman, Chad Shaw, Xin Shi, George Weissenberger,
Marjorie Withers, Svetlana A. Yatsenko, Elaine H. Zackai, Pawel Stankiewicz, and James R. Lupski
The duplication 17p11.2 syndrome, associated with dup(17)(p11.2p11.2), is a recently recognized syndrome of multiple
congenital anomalies and mental retardation and is the first predicted reciprocal microduplication syndrome described—
the homologous recombination reciprocal of the Smith-Magenis syndrome (SMS) microdeletion (del(17)(p11.2p11.2)).
We previously described seven subjects with dup(17)(p11.2p11.2) and noted their relatively mild phenotype compared
with that of individuals with SMS. Here, we molecularly analyzed 28 additional patients, using multiple independent
assays, and also report the phenotypic characteristics obtained from extensive multidisciplinary clinical study of a subset
of these patients. Whereas the majority of subjects (22 of 35) harbor the homologous recombination reciprocal product
of the common SMS microdeletion (∼3.7 Mb), 13 subjects (∼37%) have nonrecurrent duplications ranging in size from
1.3 to 15.2 Mb. Molecular studies suggest potential mechanistic differences between nonrecurrent duplications and
nonrecurrent genomic deletions. Clinical features observed in patients with the common dup(17)(p11.2p11.2) are distinct
from those seen with SMS and include infantile hypotonia, failure to thrive, mental retardation, autistic features, sleep
apnea, and structural cardiovascular anomalies. We narrow the critical region to a 1.3-Mb genomic interval that contains
the dosage-sensitive RAI1 gene. Our results refine the critical region for Potocki-Lupski syndrome, provide information
to assist in clinical diagnosis and management, and lend further support for the concept that genomic architecture incites
genomic instability.
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Nonallelic homologous recombination (NAHR) between
region-specific low-copy repeats (LCRs) (also known as
“segmental duplications”) is a major cause of DNA rear-
rangements associated with many genomic disorders.1,2
The proximal short arm of chromosome 17 is particularly
rich in LCRs and is a regional locus for four genomic dis-
orders, including Charcot-Marie-Tooth disease type 1A
(CMT1A [MIM 118220]),3 hereditary neuropathies with
liabilities to pressure palsies (HNPP [MIM 162500]),4
Smith-Magenis syndrome (SMS [MIM 182290]),5 and the
recently recognized duplication 17p11.2 syndrome.6 The
proximal and distal SMS LCRs (called “SMS-REPs”)7 me-
diate the common deletion and reciprocal duplication at
meiosis, resulting in SMS and duplication 17p11.2 syn-
drome, respectively.8,9 The architectural features of the ge-
nome in this region also stimulate nonrecurrent con-
stitutional chromosomal rearrangements that yield
different-sized deletions and duplications,10,11 transloca-
tions,11 marker chromosomes,12–14 and somatic rearrange-
ments involving 17p11.2.15
SMS is a well-characterized syndrome comprising mul-
tiple congenital anomalies and mental retardation and is
associated with a heterozygous 17p11.2 deletion or point
mutation of the retinoic acid inducible 1 gene (RAI1 [MIM
607642]) that maps within 17p11.2.16–22 Of the patients
with SMS who harbor the deletion, ∼70%–80% have the
recurrent ∼3.7-Mb common deletion mediated by NAHR
with the proximal and distal SMS-REPs as recombination
substrates,5,18 whereas the remainder have smaller or larger
deletions apparently stimulated by other LCRs in the
region.11,23
Like SMS, duplication 17p11.2 syndrome is also asso-
ciated with congenital anomalies and neurodevelopmen-
tal and behavioral phenotypes, yet the clinical features of
each syndrome are distinct. Cytogenetic and clinical fea-
tures of persons with partial trisomy of proximal 17p have
been described, mostly in isolated case reports or literature
reviews, and nonspecific and noncharacterizing findings
include developmental delay, mental retardation, and dys-
morphic features.12,14,24–30 Many cases of 17p duplication
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have been defined only by routine G-banded chromo-
some analyses and FISH, and, in these reports, the dupli-
cated regions are not well characterized at the molecular
level. Elsewhere, we described patients with the predicted
reciprocal recombination product of the common SMS
deletion, dup(17)(p11.2p11.2), and we found, from the
limited information available, that the phenotype
was mild compared with that of individuals with
del(17)(p11.2p11.2).6 Only one of the patients (patient
990) participated in a systematic clinical evaluation in the
General Clinical Research Center (GCRC) at Texas Chil-
dren’s Hospital, and more-detailed findings are described
here. Interestingly, patient 990 and the patient described
by Moog et al.29 were reported to have features of autism.
Patients with duplication of only the RAI1 locus have not
been described.
Here, the molecular assays of 35 subjects with
dup(17)(p11.2p11.2) are reported. Of these subjects, 22
harbor a “common” duplication (∼3.7 Mb), and 13 harbor
nonrecurrent duplications ranging in size from 1.3 to 15.2
Mb, as determined by multiple independent molecular
assays. Phenotypic characterization of this microdupli-
cation syndrome is achieved, not only by review of the
medical literature and available medical records, but
also by systemic multidisciplinary clinical evaluations
through a clinical protocol in the GCRC of a subset of
10 subjects, including 1 subject who harbors the smallest
duplication identified to date. Apart from developmental
delay, language impairment, and cognitive impairment,
the most frequent clinical features in persons with
dup(17)(p11.2p11.2) are hypotonia, poor feeding and fail-
ure to thrive in infancy, oral-pharyngeal dysphasia, autis-
tic features, obstructive and central sleep apnea, structur-
al cardiovascular abnormalities, electroencephalogram
(EEG) abnormalities, and hypermetropia. Features re-
ported in 150% of patients with the SMS deletion17,18 that
either are not observed or are seen only infrequently in
the duplication 17p11.2 syndrome include short stature,
hearing impairment, otolaryngologic abnormalities, oph-
thalmic abnormalities such as myopia and iris hamarto-
mata, genitourinary and/or renal anomalies, clinically sig-
nificant scoliosis, and hypercholesterolemia. Because
duplication 17p11.2 syndrome is a distinct clinical entity
from its recombination reciprocal and because the cyto-
genetic nomenclature can be cumbersome when used to
refer to affected individuals, we propose that this newly
characterized microduplication syndrome be referred to
by the eponym “Potocki-Lupski syndrome” (PLS).
Material and Methods
Human Subjects
Thirty-five subjects (table 1) with duplication of the proximal
short arm of chromosome 17 were enrolled in a molecular pro-
tocol that was approved by the Baylor College of Medicine (BCM)
Institutional Review Board (IRB). Of these subjects, 10 (age range
25 mo to 14.5 years; 6 males) also participated in a BCM IRB–
approved multidisciplinary clinical study through the GCRC at
the Texas Children’s Hospital. Informed consent was obtained
from the participants and parents or legal guardians. All but two
were ascertained through an abnormal G-banded chromosome
analysis, although many subjects had at least one chromosome
analysis that was interpreted as normal. The diagnosis for two
recently identified patients was confirmed by a commercially
available array comparative genomic hybridization (array CGH)
performed after a normal G-banded chromosome analysis (pa-
tients 2543 and 2555) and subtelomeric FISH analysis (patient
2543).
Clinical evaluations performed at the GCRC included physical
examination, developmental and cognitive profiles, psychiatric
history and diagnostic review, speech and language assessment,
ophthalmologic and otolaryngologic examinations, audiologic
assessment, swallow-function study, echocardiogram, electrocar-
diogram, overnight sleep study and multiple sleep latency test
that included an EEG, renal ultrasound, scoliosis survey, radio-
graphs of forearms and hands, fasting lipid profile, and thyroid
function studies. Available medical records and previously re-
ported data were reviewed for the subjects who did not participate
in the multidisciplinary clinical protocol. Clinical information
and/or partial molecular analyses have been reported elsewhere
for subjects 504,6,26,31 527,31,32 563,25,31 621,31 990,6 1006,6,33 1192,6
1251,6,34 1353,6 1364,6 1458,28 1861,30 and 2337 (L. E. L. M. Vissers,
P. Stankiewicz, S. A. Yatsenko, E. Crawford, H. Creswick, V. K.
Proud, B. B. A. de Vries, R. Pfundt, C. L. M. Marcelis, J. Zackowski,
W. Bi, A. Geurts van Kessel, J. R. Lupski, and J. A. Veltman, per-
sonal communication).
Cytogenetic Analysis
Peripheral blood samples for FISH were collected in green-top
tubes containing sodium heparin. BAC DNA was labeled by nick
translation with digoxigenin (Roche) or biotin (Invitrogen). Dual-
color FISH analysis was performed on metaphase and interphase
preparations of blood lymphocytes or lymphoblastoid cells as
described elsewhere.35 The duplication was confirmed by inter-
phase FISH analysis with probes specific for FLI136 and ZFP179
(ZNF179),37 each of which maps within the SMS common dele-
tion region; for analyses of patients identified more recently, a
probe specific for RAI1 was used.38 The probe specific for the pe-
ripheral myelin protein 22 gene39 (PMP22 [MIM 601097]), mapping
within the commonly duplicated CMT1A region, was the control.
Dual-color FISH by use of SMS-REP flanking clones as probes11
was applied to patients 2555 and 2571 to confirm their common
duplications. For determination of proximal breakpoints, 17 a-
satellite centromeric probe (D17Z1) (Oncor) and BAC RP11-22N2,
which maps to 17q11.1, were directly labeled as probes.
Pulsed-Field Gel Electrophoresis (PFGE) Analyses
PFGE was performed on subject samples as described elsewhere.5,6
In brief, high-molecular-weight genomic DNA was digested with
the rare cutter restriction endonuclease NotI, was separated by
PFGE, and, after Southern blotting, was probed with a 1.1-kb DNA
fragment corresponding to CLP1, which maps within both prox-
imal and distal copies of SMS-REPs. The duplication is considered
to be common if the two breakpoints map within the proximal
and distal SMS-REPs, and it is distinguished from uncommon
duplication by a unique de novo ∼1.1-Mb NotI band, correspond-
ing to the rearrangement-specific common junction fragment.
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Table 1. Summary of Cytogenetic and Molecular Analyses of Subjects
Subjecta Karyotype
Duplication
Type
(Size in Mb) Mechanismb
Breakpointc
Distal Proximal
5046,26,31 46,XY,dir dup(17)(pter-p11.2:p12-p11.2:p11.2-qter) Common P, inter … …
52731,32 46,XY,dup(17)(p11.2p12) (10.5) M, intra RP11-756K11 RP11-822E23
56325,31 46,XX,dup(17)(p11.2p12) (5.5) P RP11-726O12 RP11-98L14
62131 46,XY,inv dup(17)(p13.3p11.2) Complex M Outside RP11-45M22
9906 46,XY,dup(17)(p11.2p11.2) Common P, inter … …
10066,33 46,XX,del(17)(p12p12)dup(17)(p11.2p11.2) Common P, intra RP11-92B11 RP11-434D2
11926 46,XX,dup(17)(p11.2p11.2) Common P, inter … …
1229 46,XY,dup(17)(p11.2p11.2) (6.4) P, intra RP11-849N15 Outside
12516,34 46,XX,dup(17)(p11.2p11.2) Common P, intra … …
13536 46,XY,dup(17)(p11.2p11.2) Common M, inter … …
13646 46,XY,dup(17)(p11.2p11.2) Common M, intra … …
145828 46,XY,dup(17)(p11.2p11.2) (8.2) M, intra RP11-590H8 Outside
1529 46,XX,dup(17)(p11.2p11.2) Common … … …
1579 46,XY,dup(17)(p11.2p11.2) Common M, inter … …
1602 46,XY,dup(17)(p11.2p11.2) Common … … …
1618 46,XY,dup(17)(p11.2p11.2) Common P, inter … …
1632 46,XY,dup(17)(p11.2p11.2) Common M, inter … …
1671 46,XX,dup(17)(p11.2p11.2) Common M, intra … …
1786 46,XX,dup(17)(p11.2p11.2) Common P, intra … …
1789 46,XX,dup(17)(p11.2p11.2) Common P, intra RP11-92B11 RP11-434D2
1838 46,XY,dup(17)(p11.2p11.2) Common P, intra … …
186130 46,XX,dic(17)dup(17)(p10p11.2) (7.1) M, intra RP11-998F8 Outside
1913 46,XX,dup(17)(p11.2p11.2) Common P, intra RP11-92B11 RP11-434D2
2153 46,XY,dup(17)(p11.2p12) Complex P, inter RP11-92B11 RP11-434D2
2167 46,XX,dup(17)(p11.2p11.2) Common P RP11-92B11 RP11-434D2
2211 46,XY,dup(17)(p11.2p12) (8.2) M, intra RP11-590H8 Outsidee
2306 46,XY,dup(17)(p11.2p11.2) Common M, inter … …
2337d 46,XY,der(17).ish del(17)(p13.3)dup(17)(p11.2p12)
inv(17)(p11.2p13.3)
Complex M, intra RP11-131K5 RP11-311F12
2362 46,XY,dup(17)(p11.2p11.2) (6.9) … RP11-64B12 RP11-822E23e
2414 46,XY,dup(17)(p11.2p11.2) Common … RP11-92B11 RP11-434D2
2440 46,XX,dup(17)(p11.2p11.2) (5.0) P, inter RP11-385D13 RP11-434D2
2488 47,XYY,dup(17)(p11.2p11.2) (7.6) M, intra RP11-601N13 RP11-822E23e
2543 46,XY (1.3) M, inter RP1-48J14 RP11-258F1
2555 46,XX Common M, inter RP11-92B11 RP11-434D2
2571 46,XX,dup(17)(p11.2p11.2) Common P, inter RP11-92B11 RP11-434D2
NOTE.—Although initial chromosome analyses may have been normal, the result leading to referral is given. All subjects with a common ∼3.7-
Mb duplication had an ∼1.1-Mb junction fragment evidenced by PFGE. No patient with a large or small duplication had this junction fragment. All
subjects except 621 were duplicated by FISH analysis performed with FLI1 and/or RAI1.
a Laboratory numbers are given, and citations of references are included if the subject was described elsewhere.
b M p maternal; P p paternal; inter p interchromosomal; intra p intrachromosomal.
c These breakpoint data are from array CGH. “Outside” indicates that the breakpoint is outside array detection.
d L. E. L. M. Vissers, P. Stankiewicz, S. A. Yatsenko, E. Crawford, H. Creswick, V. K. Proud, B. B. A. de Vries, R. Pfundt, C. L. M. Marcelis, J.
Zackowski, W. Bi, A. Geurts van Kessel, J. R. Lupski, and J. A. Veltman, personal communication.
e The proximal breakpoint is located within the pericentromeric region as determined by FISH.
Array CGH
A custom human 17p array was developed with the total of 83
human BAC/PAC clones from 17p, tiling an 11-Mb region around
RAI1 that spans the genomic interval from BAC clone RP11-
462C21 in 17p13.1 to BAC clone RP11-1109M24 in 17p11.1 and
includes 10 representative clones in 17p13. Sixteen control clones
were from chromosomes other than chromosome 17. One PAC
clone, RP5-836L9, was included in our array but was later ex-
cluded from our analysis after invalidation by FISH analysis.
Clones CTD-457L16 and RP11-160E2 are in a region with copy-
number variations (CNVs).40 Clones were printed in quadrupli-
cate. Array printing and hybridization were performed as de-
scribed elsewhere.41 Reference genomic DNA was prepared from
a sex-matched normal individual. Each patient was examined
twice with dye reversal, and the final result was a normalized
combination of the two hybridization experiments. The details
for data processing were described elsewhere.10
Genotyping
We determined the parental origin of the duplicated chromo-
somes and recombination mechanisms, using a combination of
microsatellite haplotype reconstruction and the segregation of
marker genotypes on genomic DNA, as described elsewhere.6
Size and relative intensities of the peaks were calculated with
GeneMapper (v.3.7) software (Applied Biosystems). Phases of pa-
rental haplotypes were determined on the bases of the most par-
simonious explanation for observed genotypes in the patient and
under the assumption of no recombination.
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Figure 1. Identification of the common duplication and differentiation from unusual-sized duplications by PFGE analysis. An ∼1.1-
Mb novel junction (jct) fragment was predicted for the common duplication after the genomic DNA was digested with NotI, was separated
by PFGE, and was probed with a genomic fragment from the CLP gene. An asterisk (*) indicates the subjects who harbor this junction
fragment. Junction fragment data from subject 1192 was reported elsewhere.6 Subject 2555 is shown in both gel segments. The ∼1.1-
Mb junction fragment was not observed in the parents, which is consistent with a de novo event. A junction fragment was not observed
in 13 of the 35 subjects, indicating that those 13 have unusual-sized duplications.
Results
Proximal 17p Duplications
The common duplication in chromosome 17p11.2 is an
∼3.7-Mb interstitial duplication that is mediated by the
distal and proximal SMS-REPs and is the reciprocal of the
common deletion observed in SMS. A de novo recombi-
nation-specific junction fragment of ∼1.1 Mb was detected
previously by PFGE in seven patients with the common
duplication (patients 504, 990, 1006, 1192, 1251, 1353,
and 1364).6 This ∼1.1-Mb junction fragment was also de-
tected in 15 of 28 new subjects (fig. 1). The junction frag-
ment was not observed in the parental samples and thus
is deemed to occur de novo in all subjects. Thirteen sub-
jects had no junction fragment or had a junction fragment
smaller or larger than 1.1 Mb (fig. 1), indicating an un-
usual-sized duplication. Thus, 22 (∼63%) of the 35 subjects
with duplication 17p11.2 harbor a common recurrent du-
plication (table 1).
A custom array CGH identified effectively four distinct
genomic disorders in proximal 17p.10 To define the du-
plication breakpoints in subjects with PLS, we extended
the previous array to cover almost the entire short arm of
chromosome 17, spanning the genomic regions from
17p13 to the centromere, such that the array tiled the
genomic regions that correspond to band 17p12 and sub-
bands 17p11.2 and 17p11.1. Array CGH was performed
on samples from seven patients with a common dupli-
cation (patients 1006,10 1789,10 1913,10 2167, 2414, 2555,
and 2571), and the results indicated that each patient har-
bors a common duplication spanning the genomic region
from the BAC clone RP11-92B11, mapping in the distal
SMS-REP, to BAC clone RP11-434D2, mapping in the prox-
imal SMS-REP, which independently confirms that the re-
combination-specific junction fragment identified by
PFGE is an indicator of a common duplication (table 1,
fig. 2, and data not shown).
We previously developed a rapid and reliable FISH assay
to distinguish common from nonrecurrent SMS deletions
with dual-color interphase FISH with the use of SMS-REP–
flanking clones as probes,11,18 which can also distinguish
common from nonrecurrent duplications. The distal SMS-
REP–flanking BAC clones RP11-416I2 and RP11-209J20
and the proximal SMS-REP–flanking clones RP11-98L14
and CTD-2010G8 were used concurrently in FISH on in-
terphase lymphocytes. We applied this novel FISH test to
the analysis of patients with proximal 17p duplications.
As predicted, in the common duplications, three signals
were observed for the BAC probes RP11-416I2 and CTD-
2010G8 within the SMS common deletion interval, but
only two signals were observed for the probe telomeric to
the distal SMS-REP (RP11-209J20) and the probe centro-
meric to the proximal SMS-REP (RP11-98L14) (fig. 2D–2H).
Our previous studies showed that recombination re-
sulting in common recurrent deletions in 17p11.25,42 and
uncommon nonrecurrent deletions11 showed no apparent
bias in parental origin and that these occurred via both
inter- and intrachromosomal mechanisms. To investigate
the genetic recombination mechanism for proximal 17p
duplication, we reconstructed the haplotypes of eight pa-
tients with common duplication dup17p11.2, using 10
microsatellite markers, and we analyzed the segregation
of marker genotypes (table 1 and fig. 3). These data are
consistent with our previous results for 11 families42 and
further confirm that there is no substantial bias for pa-
rental origin of the duplication and that the crossover
occurs via interchromosomal and intrachromosomal
mechanisms at approximately equal frequencies.
Uncommon Duplications and Their Breakpoints
In our cohort, 13 subjects (37%) had 17p duplications that
were not mediated by the distal and proximal SMS-REPs
and are thus classified as uncommon duplications. Not
Figure 2. A, Array CGH analysis of patients 2571 and 2543. A combined result from two dye-swap experiments was presented with
normalized log2(Cy3/Cy5) ratios of patient versus control for each individual clone plotted on the Y-axis and represented by dots with SD.
Patient 2571 has the common duplication spanning a region from the distal to the proximal SMS-REP. Patient 2543 harbors a duplicated
genomic region smaller in size than the common recurrent dup(17)(p11.2p11.2). The size of the duplicated genomic interval is ∼1.3 Mb,
spanning from the distal SMS-REP to a site telomeric to the middle SMS-REP. Since patient 2543 exhibits the key phenotypic features of
PLS, this ∼1.3-Mb duplicated interval represents the critical region. The 14 genes, including RAI1, contained within this critical interval
are listed. The regions of the critical duplication and the common duplication are indicated by thick horizontal lines. The BACs in the
vicinity of the breakpoints are indicated by short black lines. Note that one clone, CTD-457L16, located in a CNV region between the middle
and the proximal SMS-REPs showed increased copy number. B and C, FISH analyses of interphase nuclei, which detected the breakpoints
in subject 2543. BAC probes used in FISH analysis are indicated by red or green circles. In panel A, the probes are differentially labeled
to give a green signal for RP11-209J20 and a red signal for RP11-416I2. In panel B, the presence of three red signals (RP11-416I2) and
two green signals (RP11-209J20) indicate that the distal breakpoint maps within the distal SMS-REP. In panel C, the presence of three red
signals (RP11-258F1) and two green signals (RP11-189D22) indicate that the proximal breakpoint maps distal to the middle SMS-REP. D–
H, Common dup(17)(p11.2p11.2) detected by a FISH assay. D, Schematic representation of a dual-color interphase FISH assay developed
to screen for common versus unusual duplications. A map of chromosome 17p11.2 with the placement of FISH probes is above. The SMS-
REP–flanking clones are differentially labeled and detected with green and red dyes, respectively. The presence of three red signals indicates
that the breakpoints map between RP11-209J20 and RP11-416I2 (E) and between CTD-2010G8 and RP11-98L14 (F). G and H, FISH analysis
of interphase nuclei of patient 2555 to confirm the common duplication. The presence of three red signals (RP11-416I2 and CTD-2010G8)
and two green signals (RP11-209J20 and RP11-98L14) indicates that the breakpoints map within the distal (G) and proximal SMS-REPs
(H). Cen p centromere; dup p duplicated chromosome 17; nl p normal chromosome 17.
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Figure 3. Pedigrees and haplotypes of 18 Houston families. The
legend is available in its entirety in the online edition of The
American Journal of Human Genetics.
surprisingly, there is imperfect correlation between G-
banded chromosome analyses and breakpoint analyses
(table 1). None of these subjects, however, showed the
∼1.1-Mb junction fragment on PFGE (table 1 and fig. 1).
The custom array CGH proved to be the most informative
and rapid method for determining the breakpoints in the
uncommon duplications. The array CGH revealed that the
centromeric breakpoints group in the pericentromeric re-
gion, with some mapping to a remaining sequencing gap
close to the centromere, and it provided evidence that
narrowed the critical region for PLS.
BAC microarray analyses have been previously per-
formed for three patients with duplication (patients 563,
1229, and 1861) on a custom array for proximal 17p.10
Although clones covering the pericentromeric region were
lacking, these subjects were found to have proximal break-
points centromeric to the LCR17pG copy.10 To further re-
fine the proximal breakpoints of the subjects with uncom-
mon duplications, we applied array CGH analysis, using
our new extended microarray, and FISH analysis of a sub-
set of subjects (figs. 4 and 5). Analysis by array CGH de-
termined that 3 of the 13 subjects (patients 621, 2153, and
2337) have more than a simple duplication of a single
region within 17p and thus are classified as having com-
plex rearrangements (table 1 and fig. 6). Of the 10 subjects
with uncommon duplications with simple rather than
complex rearrangement, 3 (patients 527, 2362, and 2488)
have a proximal breakpoint that maps within the two
overlapping BACs in the pericentromeric region, RP11-
822E23 and RP11-1109E24. Interestingly, this 17p break-
point grouping is at the gap at 21.5 Mb that is among the
nine euchromatic gaps in chromosome 17.43 It is one of
the two gaps that are apparently refractory to cloning and
are associated with primate-specific breaks in conserved
synteny.44 Four subjects (1229, 1458, 1861, and 2211) have
a proximal breakpoint that maps proximal to the BAC
RP11-1109E24, indicating that their proximal breakpoints
are in the pericentromeric region (2211) (fig. 4) or in the
centromere (186130) (fig. 6). Thus, 7 of 10 simple dupli-
cation events have breakpoints within the pericentrom-
eric or centromeric region and may have been stimulated
by pericentromeric structures. Three simple duplications
have a proximal breakpoint distant from the centromere.
The breakpoint for subject 2440 mapped within the prox-
imal SMS-REP, which was confirmed by FISH analysis (fig.
4). For subject 563, the centromeric breakpoint is located
within the BAC RP11-98L14 that contains a 23-kb ge-
nomic fragment homologous to the SMS-REPs, whereas
subject 2543 has a proximal breakpoint between the distal
and middle SMS-REPs, where no LCR has been identified
to date.
Although the proximal breakpoints in the uncommon
duplications group near the pericentromeric region, the
distal breakpoints in the 10 uncommon simple duplica-
tions did not cluster into groups (table 1 and fig. 6). Two
of the distal breakpoints map within LCR-containing BAC
clones; subject 2543 had a breakpoint in the distal SMS-
REP, and the distal breakpoint of subject 2440 is in RP11-
385D13, the BAC that resides within LCR17pA. This large
383-kb LCR is the progenitor of many repeats in 17p,43,44
encompasses the breakpoints of the evolutionary trans-
location t(4;19) in Gorilla gorilla,44,45 and contains break-
points for several different chromosome aberrations, in-
cluding the uncommon but recurrent deletions defined in
a subset of patients with SMS.23 No LCRs or other higher-
order sequence structures were identified in the other
seven distal breakpoints.
We sought to determine the parental origin of the du-
plication in the uncommon duplications and analyzed 10
families with nonrecurrent duplication (fig. 3). Parental
origin information was previously published for two ad-
ditional patients (patients 563(pat) and 621(mat)).31 In to-
tal, eight duplications are maternal in origin, whereas four
are paternal. Seven resulted from intrachromosomal re-
combination, and three from interchromosomal cross-
over. Interestingly, in each of the six patients studied (527,
1229, 1458, 1861, 2211, and 2488), the uncommon du-
plications with a proximal breakpoint close to the cen-
tromere resulted from intrachromosomal recombinations,
five of which are maternal in origin.
Subjects Who Harbor an Uncommon Duplication and Other
Rearrangements Involving 17p
Three of the 13 subjects with uncommon duplications
were found to have a complex chromosomal rearrange-
ment (table 1 and fig. 6). Subject 621 has a 15.2-Mb du-
plication that does not encompass RAI1 (fig. 6), as well as
a paracentric inversion of 17p11.2p13.3.31 As observed in
array CGH analysis and confirmed by FISH analysis, sub-
ject 2153 has two duplicated segments—the common
∼3.7-Mb duplication and a smaller duplication involving
two overlapping BAC clones (RP11-385D13 and RP11-
640I15) that are ∼1 Mb telomeric from the distal SMS-REP
(figs. 4, 5, and 6). Subject 2337 has a complex rearrange-
ment including a 5.9-Mb duplication of 17p11.2, a 1.9-
Mb deletion of 17p12 that is ∼400 kb distal to the du-
plicated region (fig. 6), and an inversion. Extensive
additional molecular analyses and breakpoint mapping of
the complex chromosomal rearrangements found in pa-
tient 2337 will be reported elsewhere (L. E. L. M. Vissers,
P. Stankiewicz, S. A. Yatsenko, E. Crawford, H. Creswick,
V. K. Proud, B. B. A. de Vries, R. Pfundt, C. L. M. Marcelis,
J. Zackowski, W. Bi, A. Geurts van Kessel, J. R. Lupski, and
J. A. Veltman, personal communication).
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Figure 4. FISH analyses of interphase nuclei for mapping of breakpoints. Above is a map of proximal 17p, with the locations of FISH
probes indicated by arrows. A–F, Centromeric breakpoints in patients 2488 (A and B), 2362 (C and D), and 2211 (E and F) mapped
within the pericentromeric region. The probes used are listed below interphase nuclei. The presence of one signal in addition to the
normal two signals indicates duplication in that region. Duplication was observed for BAC probe RP11-746M1 in 17p11.2. FISH using
centromeric probe D17Z1 and BAC probe RP11-22N2 in 17q11.1 indicated no duplication in either the centromere or 17q. G, FISH with
the proximal SMS-REP flanking clones CTD-2010G8 (red) and RP11-98L14 (green), mapping the proximal breakpoint in patient 2440 in
the proximal SMS-REP. H–J, Two separate duplications in proximal 17p in patient 2153, confirmed by FISH. Duplicated chromosome 17
is indicated by arrows. Cen p centromere.
Figure 5. Determination of duplicated regions by array CGH anal-
ysis. The legend is available in its entirety in the online edition
of The American Journal of Human Genetics.
Distinctive Phenotype of Subjects Who Harbor the Common
Duplication
The 22 subjects determined to have the common 17p11.2
duplication represent a molecularly defined cohort of pa-
tients with a gain in copy number for a discreet genomic
segment. The facial features in most patients were not
strikingly dysmorphic, yet there were shared similar char-
acteristics (fig. 7A–7J). The patient described by Kozma et
al.26 and subject 1913 described here have more-pro-
nounced facial dysmorphisms. Short stature (height !2nd
percentile) was observed in five of the seven subjects de-
scribed by Potocki et al.6; however, only one (patient 1913)
of the seven patients with the common duplication in this
cohort had short stature for her age. At age 13 years, this
patient measured at the 50th percentile for a 7.5-year-old
female. Results of growth-hormone-stimulation assays
performed before her admission to GCRC were normal.
The key clinical features of PLS are summarized in table
2. A more detailed history was available for the subjects
who participated in the multidisciplinary clinical proto-
col. The history ascertained for all subjects included in-
fantile hypotonia, poor feeding, and developmental delay.
A formal diagnosis of failure to thrive was given to five of
seven patients with the common duplication, and three
of these patients were fed by gastrostomy tube (table 2).
Gestational history was also significant in this group. Both
failure to progress in labor and subsequent cesarean sec-
tion were reported for four of the seven subjects. Inter-
estingly, three patients had an abnormal triple analyte
screen that suggested an increased risk of Down syndrome.
Prenatal chromosome analyses were performed on two
subjects, and results were interpreted as normal for both.
Four of the seven subjects were small for gestational age.
In the non-GCRC group, birth weight was provided for
11 patients, and 5 of them were small for gestational age.
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Figure 7. Facial features of PLS. A–J, Patients with the common duplication. A, Patient 2555, at age 22 mo. B, Patient 2306, at age
33 mo. C, Patient 2167, at age 3 years 3 mo. D, Patient 1671, at age 3 years 9 mo. E, Patient 1579, at age 4 years 2 mo. F, Patient
2414, at age 9 years 6 mo. G, Patient 1006, at age 14 years 2 mo. H, Patient 1618, at age 14 years 6 mo. I, Patient 990, at age 16
years 1 mo. J, Patient 1913, at age 13 years. Shared features include a broad forehead, gentle down-slant of the palpebral fissures,
and relatively long nasal tip. Younger patients have a triangular face with prominence to the angle of the jaw and micrognathia. A
more oval-shaped face and larger chin is seen in older individuals. Patients 1579 (E) and 1913 (J) were microcephalic and hyperteloric.
Patient 1913 has more pronounced facial dysmorphisms, including down-slanting palpebral fissures, low-set and posteriorly rotated
ears, and broad mouth. An interesting feature shared by most patients is an asymmetric smile that is seen in multiple photographs
taken of each patient in the GCRC and in photographs shared by their parents. K, Patient 2543, who harbors a small (∼1.3-Mb)
duplication, at age 8 years and 1 mo. L, Patient 2211, who harbors a large (8.2-Mb) duplication, at age 4 years and 10 mo. Physical
features seen in these patients are very similar to those of patients with the common duplication.
Developmental delay, cognitive impairment, and com-
munication disorders were present in all subjects (tables
2 and 3). Among the GCRC common-duplication group,
the milestone of walking was attained, on average, at age
31 mo (range 18 mo to 5 years). Speech delay, absent
speech, and other speech and language abnormalities,
such as immediate and delayed echolalia, were observed
in all subjects. Expressive and receptive language impair-
ment was clearly evident when assessed objectively by
standard means (Oral and Written Language Scales and
Preschool Language Scale–4th Edition). All GCRC subjects
demonstrated articulation dysfunction, and five demon-
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Table 2. Key Clinical Features of PLS
Trait
Patient
Non-GCRC
Subjectsa990 1579 1618 1913 2167 2306 2414 2211 2440 2543
Sex M M M F F F M M F M
Age 9 y 10 mo 4 y 2 mo 14.5 y 13 y 3 y 3 mo 2 y 9 mo 9.5 y 4 y 10 mo 2 y 1mo 8 y 1 mo
Duplicationb C C C C C C C L L S C
Obstetrical and birth history:
Birth weight low for gestational
age           5/11
Failure to progress and/or cesa-
rean section           2/8
Medical and developmental history:
Poor feeding as infantc           8/9
Gastroesophageal refluxc           3/5
Failure to thrive in infancy or
early childhoodc           5/8
Gastrostomy tube           1/8
Hypotonia as infantc           9/11
Developmental delayc           14/14
Epilepsy           1/10
Subjective sleep disturbance           4/6
Short stature    d       4/11
Neuropsychiatric evaluation:
Cognitive impairmentc           14/14
Low adaptive functionc           5/5
Autistic featuresc           1/2
Speech and language evaluation:
Language impairmentc           9/10
Articulation difficultiesc           8/9
Oral-pharyngeal dysphasiac,e          1/1
Central and/or obstructive sleep
apneac         
EEG abnormalityc          3/5
Epileptiform abnormalities on EEG          0/3
Hypermetropia seen on ophthalmic
examinationc           1/5
Hearing impairment f   f       1/6
CNS abnormality by MRI  g,h g,i g,h g,j g,j  g,i g,k  0/4
Cardiovascular abnormality         l 1/2
Structural renal anomaly           1/3
Scoliosis 110 degrees           1/3
Low total cholesterol and low LDL          
NOTE.—Plus sign () p feature present; minus sign () p feature not present.
a Data for non-GCRC subjects is given as number with trait/number tested. Male:female ratio is 6:9. Age range is 17 mo to 24 years.
b Duplication size: C p common; L p large; S p small.
c Feature observed in 70%–100% of subjects with the common duplication evaluated at GCRC.
d Not growth-hormone deficient.
e Swallow-function study with a speech pathologist present.
f Mild sensitivity loss at 4,000 Hz.
g Magnetic resonance imaging (MRI) not performed at GCRC.
h Microcephaly.
i Mild attenuation of corpus callosum.
j Mild delay in myelination.
k Possible Rathke’s cleft remnant and prominence of left semicircular canal and vestibule.
l Borderline prolonged QT interval.
strated difficulties with motor planning and/or sequenc-
ing sounds within words that indicate verbal apraxia.
Three GCRC subjects used augmentative communication,
such as manual signing and the picture-exchange com-
munication system.
Cognitive assessments by Stanford-Binet Intelligence
Scale46 or the Mullens Scales of Early Learning47 revealed
global intelligence quotients (IQs) within the mild (IQ
level 50–55 to ∼70) to moderate (IQ 35–40 to 50–55) range
of mental retardation, although two patients with the
common duplication scored within the borderline (IQ 70–
79) or low-average (IQ 80–89) range in verbal subsets (table
3). Adaptive functioning was uniformly low in all but one
subject (2306) across all domains, measured by standard-
ized score !20–69 on the Vineland Adaptive Behavior
Scales.48
Regarding behavior, the most frequent history from the
non-GCRC group was attention deficit and hyperactivity
disorder. These reports differ from the findings for psy-
chometric testing and psychiatric assessment of the sub-
jects assessed at the GCRC, for which most patients dem-
onstrated features of the autistic spectrum disorders (tables
2 and 3). Only one subject (1579) did not exhibit any
autistic characteristics on examination or have a history
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Table 3. Neuropsychiatric and Communicative Profile of PLS
Trait
Patient
Mean
Standard Score
(Proportion
Affected)a
Patient
2543990 1579 1618 1913 2167 2306 2414
Sex M M M F F F M M
Age 9 y 10 mo 4 y 2 mo 14 y 6 mo 13 y 3 y 3 mo 2 y 9 mo 9 y 6 mo 8 y 1 mo
Duplication C C C C C C C C S
Communication skills:
Receptive language 74 65 40 40 51 85 40 56 50
Expressive language 73 50 50 b 61 78 40 59 50
Total language 72 50 43 b 51 80 40 56 50
Articulation difficulties        (7/7) 
Augmentative
communication        (3/7) 
Cognitive assessment IQ/DQc:
Global 65 49 40 36 49 69 36 49 42
Verbal 78 46 46 36 37 82 38 52
Nonverbal 68 62 46 38 46 63 36 51
Adaptive function:
Behavior composited 51 39 30 42 73 27 41 28
Daily livingd 52 50 27 40 67 34 45 20
Socializationd 36 32 39 37 72 26 41 43
Behavioral features consis-
tent with autism:
Decreased eye contact        (3/7) 
Repetitive motor
mannerisms        (4/7) 
Echolalia        (6/7) 
NOTE.—Plus sign () p feature present; minus sign () p feature not present.
a Mean values for seven patients (990, 1579, 1618, 1913, 2167, 2306, and 2414).
b The complete formal language assessment not performed on this subject at GCRC. She was nearly nonverbal and used augmentative communication.
c Global, verbal, and nonverbal IQs and developmental quotients (DQs) were obtained using the Stanford-Binet Intelligence Scale–4th Edition46 and the Mullen Scales
of Early Learning,47 respectively.
d Vineland Adaptive Behavior Scales.48
of them. Autistic features gathered by history or estab-
lished on examination included decreased eye contact (3
of 7 patients), motor mannerisms or posturing (4 of 7),
sensory hypersensitivities or preoccupations (5 of 7), re-
petitive behaviors or preoccupations (5 of 7), lack of ap-
propriate functional or symbolic play (3 of 7), and lack of
joint attention (3 of 7). Patient 2414 was evaluated with
an Autism Diagnostic Interview–Revised (ADI-R) and Au-
tism Diagnostic Observation Schedule–Generic (ADOS-G),
each of which was positive for autism.
Several clinical evaluations were performed as part of
the GCRC protocol. Many studies were either not per-
formed and/or were not reported for other molecularly
characterized patients. No parents (of the GCRC cohort)
reported disturbed sleep in their children, and no patient
exhibited substantial signs of airway obstruction by oto-
laryngologic examination. Thus, the abnormalities on
overnight sleep study were unexpected in this cohort, re-
vealing sleep-disordered breathing characterized by ob-
structive sleep apnea, central sleep apnea, and significant
oxygen desaturation and hypercarbia. In addition, the
EEG findings were abnormal for all subjects with the com-
mon duplication. Six had a slow occipital dominant
rhythm (“alpha”), and four had generalized and/or focal
epileptiform abnormalities (spikes, sharp waves, and spike
and slow-wave discharges); no EEG seizure discharges or
clinical seizures were recorded. No subject received anti-
seizure medication or had a history of seizures. Abnor-
malities of the circadian rhythm of melatonin have been
established in persons with deletion 17p11.2 (SMS), yet
we did not find this to be a feature in one patient with
duplication 17p11.2.49
Although organ developmental abnormalities were not
recognized as major features of individuals with duplica-
tion 17p11.2,6,24,26,27,29,34 through systematic evaluation of
the GCRC patients, we found that more than half showed
structural cardiovascular anomalies when assessed by
echocardiography (table 2). Patient 1913 had a large se-
cundum type atrial septal defect with left-to-right shunt-
ing and moderately dilated aortic root; patient 2167 evi-
denced a small secundum atrial septal defect with
left-to-right shunting; patient 2306 manifested bicom-
missural aortic valve and patent foramen ovale; and pa-
tient 2414 had a mildly dilated pulmonary annulus. Bal-
arin et al.28 described a patient with a large duplication
17p11.2 and Alport syndrome, yet the only abnormality
seen on renal ultrasound in the GCRC subjects was poor
corticomedullar differentiation in one patient (1913). Re-
nal ultrasound was normal in all other subjects. Urinalysis
and measures of blood urea nitrogen and creatinine were
normal in all subjects studied in the GCRC. Few patients
evaluated in the GCRC manifested mild scoliosis (!10 de-
grees) (2 of 7 subjects), mildly low total cholesterol and
low-density lipoproteins (LDL) (3 of 7 subjects), and
mildly low thyroxin with normal levels of thyroid-stim-
ulating hormone (2 of 7 subjects).
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An Uncommon Duplication That Narrows the Critical
Region to a 1.3-Mb Interval That Includes RAI1
The size of duplication in the 13 patients with uncommon
nonrecurrent duplication studied ranged from 1.3 Mb to
115.2 Mb. The smallest duplication (in subject 2543) was
beyond the limits of resolution of G-band analysis and
was detected by array CGH. We determined the break-
points of the duplicated segment in subject 2543 to be at
BACs RP11-92B11 and RP11-258F1 (table 1 and fig. 2A).
The telomeric breakpoint maps within the distal SMS-REP,
and the centromeric breakpoint is distal to the middle
SMS-REP. FISH analysis confirmed the distal breakpoint by
use of SMS-REP-flanking BAC clones RP11-209J20 and
RP11-416I2 as probes (fig. 2B) and confirmed the proximal
breakpoint by use of clones RP11-258F1 and RP11-189D22
as probes (fig. 2C). This duplicated segment contains 14
genes, including RAI1, the major contributing gene for the
reciprocal deletion causing SMS.
Genotype-Phenotype Correlation in Patients with Proximal
17p Duplication
The cardinal features of PLS have now been defined by
multidisciplinary clinical analysis of a cohort of seven pa-
tients with the common duplication and have been sup-
ported by review of medical records of subjects with com-
mon duplication who did not participate in the clinic
protocol (table 2). Variability in the phenotype is observed
despite a common genomic imbalance in these subjects.
However, it is expected that persons harboring large du-
plications that encompass the CMT1A region within
17p12 will have a more severe phenotype, including pe-
ripheral neuropathy.29,31,32,50 Of the subjects with uncom-
mon duplications, patients 2543, 2440, and 2211 were
evaluated at the GCRC (table 2 and figs. 2 and 6).
Patient 2211 (fig. 7L), whose duplication encompasses
PMP22, has features typical of PLS, including hyperme-
tropia, speech and language impairment, autistic spec-
trum disorder, sleep apnea, oral-pharyngeal dysphagia,
and EEG abnormalities that include epileptiform changes,
such as multifocal spike and wave discharges. Mild sco-
liosis (!9 degrees) was also seen and was not unexpected,
given his peripheral neuropathy. Features of this patient
that have not been observed in persons with the common
duplication include severe peripheral neuropathy, syrinx
of the spinal canal, renal anomaly (malrotation of the left
kidney), and severe and hemodynamically significant car-
diovascular disease. Whereas a moderate aortic root di-
latation and bicommissural aortic valve were observed in
subjects with the common duplication (patients 1913 and
2306, respectively), patient 2211 had a massively dilated
aortic root and bicommissural aortic valve requiring sur-
gical intervention.
Clinical assessments in conjunction with molecular
analyses of subjects with smaller duplications can enable
definition of the critical region for PLS. Subject 2543 (fig.
7K), who has the smallest duplication (1.3 Mb) reported
to date, was evaluated at the GCRC at age 8 years and 1
mo; his key clinical features are listed in table 2. As an
infant, he displayed hypotonia, failure to thrive, poor
sucking, vomiting, and recurrent respiratory illnesses. Al-
though a gastrostomy tube was avoided, a prolonged pe-
riod (nearly 12 h per d) was required to complete his feed-
ing. Developmental milestones were delayed; he sat at age
9 mo, crawled at age 13 mo, and walked at age 20 mo.
He was toilet trained at age 6–7 years and began reading
single words at age 7 years. He was given a formal diag-
nosis of autism at age 3 years, was still nonverbal at age
8 years, and uses an augmentative communication device.
Chromosome analysis was normal in this patient, yet a
diagnosis of autism and mental retardation prompted fur-
ther analysis with array CGH, thus revealing a duplication
involving 17p11.2. Clinical evaluation at the GCRC re-
vealed normal ophthalmic, otolaryngologic, and audiolgic
examinations and normal studies of lipid levels and thy-
roid function. Scoliosis survey revealed a 14-degree cur-
vature of the thoracolumbar spine that was not clinically
apparent. Echocardiogram was normal, although an elec-
trocardiogram revealed a borderline-prolonged QT inter-
val (a measure of the time between the start of the Q wave
and the end of the T wave in the heart’s electrical cycle).
The 24-h sleep study was significant because of multiple
nocturnal awakenings and mild obstructive sleep apnea
associated with oxygen desaturation. Results of the EEG
performed concurrently with the sleep study were normal.
As observed in persons with the common duplication,
subject 2543 exhibited impairment in language, cogni-
tion, and adaptive function. The previous diagnosis of au-
tism was confirmed by testing using ADI-R and ADOS-G.
Among this cohort, patient 62131 is the only one who
has a large duplication outside the critical region and has
a normal dosage of the RAI1 gene. Dysmorphic features,
failure to thrive, mental retardation, and CMT1A neurop-
athy were reported. However, many of the key clinical
features of PLS, including autistic features, EEG abnor-
malities, hypermetropia, and sleep apnea, were not eval-
uated for this patient; thus, further genotype-phenotype
correlation is not possible.
Discussion
Autistic Spectrum Disorder, a Feature of PLS
PLS (dup(17)(p11.2p11.2)) is clinically recognizable and is
associated with hypotonia and failure to thrive in infancy
and early childhood, developmental delay, mental retar-
dation, severe communication disorder, autistic spectrum
disorder, sleep disordered breathing, EEG abnormalities,
cardiovascular anomalies, and hypermetropia. We have
defined this syndrome on the basis of a shared molecular
structural abnormality6 and, by systematic analysis of a
larger cohort of subjects, have elucidated further the clin-
ical and behavioral phenotype of this microduplication
syndrome. Initially, we hypothesized that patients with
duplication 17p11.2 did not come to medical attention
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because of the milder phenotype.6 However, our findings
now reveal that these patients may have substantial med-
ical illness as well as neurobehavioral abnormalities that,
except for the developmental delay, may go unrecognized
until later infancy or childhood. Most patients likely elude
an etiological diagnosis because of the limitations of the
current conventional cytogenetic analyses.
In the absence of rearrangement-type–specific selection,
the prevalence of dup(17)(p11.2p11.2) should be equal to
that of its recombination reciprocal del(17)(p11.12p11.2).
However, because of the subtle appearance of the dupli-
cated G-light band, and since interphase FISH is required
to resolve visually the duplicated region, many patients
escape ascertainment by conventional cytogenetic meth-
ods. The availability of array CGH in clinical diagnostic
laboratories has revolutionized clinical genetics, because
it enables high-resolution genome analysis with highly
sensitive and specific detection of deletion or duplication
of targeted regions of the human genome. The array CGH
assays that are clinically implemented comprise a targeted
array of clones with which unbalanced rearrangements of
the telomeres and regions associated with genomic dis-
orders can be resolved.41,51,52 We expect that the recognized
prevalence of the duplication 17p11.2 syndrome will in-
crease as this method becomes more widely used by
physicians.
Another essential factor in the recognition of this dis-
order is the appreciation of the associated behavioral char-
acteristics.6 Our objective clinical assessment of the du-
plication 17p11.2 syndrome clearly indicates features of
autistic spectrum disorder in the vast majority of patients.
Linkage studies document evidence of a locus that confers
susceptibility to attention deficit hyperactivity disorder in
17p11.2.53,54 There have been no linkage or association
studies reporting a susceptibility locus for autism in
17p11.2, but two studies suggest such a locus in
17q11.2.55,56 We should note that genomic duplications
can result in the misinterpretation of marker genotypes
because of the triallelic nature of a duplicated locus com-
pared with the normal biallelic locus.50,57,58
Until these clinical features are widely recognized, most
patients with dup(17)(p11.2p11.2) will likely receive a di-
agnosis by a laboratory test before anyone suspects a spe-
cific syndrome. Nonetheless, the phenotypic delineation
presented here will allow appropriate medical manage-
ment, clinical care, and anticipatory guidance for persons
with PLS. For example, because autistic spectrum disorder
is common to PLS, patients should undergo diagnostic
analysis specifically for autism (ADI-R and ADOS-G), and,
if criteria are met, specific therapy, such as targeted social
communication treatment, should be considered.59 Even
in the absence of a formal diagnosis of autism, considering
the significant communication impairment in persons
with PLS, specific speech and language interventions and
augmentative communication can be integrated into their
education and language-development programs. Abnor-
malities noted during the sleep studies may have substan-
tial consequences for daytime cognition and behavior;
thus, overnight sleep studies and clinical assessments
should be considered as part of the evaluation of persons
with PLS. Although no subject whom we evaluated had
clinically recognized seizures, four had potentially epilep-
tiform abnormalities of generalized and focal character on
EEG and may be at an increased risk of future epilepsy.
Thus, any medications that decrease the seizure threshold
should be prescribed with caution. Although still consid-
ered preliminary, our findings also suggest that recom-
mendations for clinical care of persons with PLS should
include echocardiography with evaluation of the aortic
root. Other evaluations, such as audiologic testing, oph-
thalmic examination, and routine studies of blood and
urine chemistry, tend to be standard recommendations
for most patients evaluated for cognitive impairment and
behavioral abnormalities.
The Critical Region for PLS
Whereas both SMS due to deletion 17p11.2 and PLS due
to duplication 17p11.2 share the common recombination
mechanism, our data show that the clinical features are
different and, at times, are even divergent between these
two genomic disorders. For example, myopia is common
in SMS, whereas hypermetropia is common in PLS, and
hyperlipidemia is common in SMS, whereas low choles-
terol is a feature of PLS. Thus, CNV resulting from dele-
tions and duplications can cause a clinical phenotype, but
the manifestation can differ for genomic losses and ge-
nomic gains. Although 150 genes map to the commonly
deleted SMS interval, only RAI1 has been shown to be
mutated in patients with nondeletion SMS.19,20,60,61 Even
though haploinsufficiency of RAI1 is necessary and suf-
ficient to cause many of the clinical features of SMS, the
full phenotypic spectrum of SMS is evident only in persons
harboring the chromosomal deletion.18,62 Since no patient
has been identified with a duplication involving RAI1
alone, it remains to be determined whether RAI1 is the
major dosage-sensitive gene of consequence in PLS. A sin-
gle subject (2543) narrows the critical region for PLS to a
1.3-Mb interval spanning from the distal SMS-REP to a site
!200 kb telomeric from the middle SMS-REP. This indi-
vidual exhibits the clinical and behavioral phenotype of
PLS, including autistic spectrum disorder. Interestingly,
this patient also lacks two frequent features found in per-
sons with the common duplication—namely, hyperme-
tropia and EEG abnormalities. Thus, one can speculate
that dosage abnormalities of RAI1 or other genes within
this region are not responsible for these findings. Several
more patients need to be evaluated to enable appreciation
of the clinical variability in persons with identical molec-
ular aberrations.18
It is challenging to determine the dosage-sensitive
gene(s) responsible for PLS, the dup(17)(p11.2p11.2) syn-
drome. Whereas the dosage-sensitive gene for deletion
syndromes can often be determined by the identification
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of rare patients with loss-of-function (e.g., nonsense or
frameshift allele) point mutations consistent with hap-
loinsufficiency, duplication syndromes provide greater
challenges. Among the PLS candidates, RAI1 may be the
culprit, since it represents a dosage-sensitive gene that has
been shown to be responsible for the majority of SMS
features. Animal models are useful adjuncts to clinical
analyses because they allow targeted investigation and
controlled observation. Human chromosome 17p11.2 is
syntenic to the 32–34 cM region of murine chromosome
11. CNV of RAI1, including decreased or increased dosage,
causes distinct neurobehavioral and craniofacial conse-
quences in both humans and mice, indicating that a crit-
ical window of gene expression exists for RAI1.63 Interest-
ingly, the deletion and duplication animals recapitulate
some of the physical and neurobehavioral features seen
in patients.64,65 We have shown recently that both physical
and behavioral features observed in Dp(11)17/mice can
be rescued by restoring the normal Rai1 gene dosage in
Dp(11)17/Rai1 compound heterozygous animals.63 Fur-
ther analyses may help to provide insights that could be
applicable to clinical management and therapy.
Stimulation of Chromosome 17p Duplication by Genomic
Architecture
Consistent with the finding that the majority of patients
with SMS have a common deletion, the common recur-
rent duplication of proximal 17p also predominates. These
observations further support the concept that directly or-
ientated highly homologous LCRs represent a major factor
conferring susceptibility to dosage imbalance of genomic
material by serving as substrates for NAHR. Uncommon
recurrent deletions ∼5 Mb in size, by use of alternative
LCRs in proximal 17p as recombination substrates, have
been reported in six patients.23 However, none of the un-
common 17p duplications share breakpoints with the un-
common recurrent deletions. Identification of the pre-
dicted reciprocal duplication of the uncommon recurrent
deletion in proximal 17p requires investigation of addi-
tional patients with duplication.
Many nonrecurrent deletion breakpoints in the proxi-
mal 17p occurred within LCRs.11 In this study, three prox-
imal and two distal nonrecurrent duplication breakpoints
mapped within BACs that contain LCRs. In addition,
seven proximal duplication junctions grouped at or near
the pericentromeric region. Therefore, genome architec-
ture likely stimulates both nonrecurrent deletions and du-
plications in proximal 17p.
A wide spectrum of structural genomic aberrations has
been reported in proximal 17p, likely because of both en-
richment of LCRs in this highly unstable region and as-
certainment secondary to the presence of genes (e.g., RAI1
and PMP22) in which copy-number alteration conveys
clinical phenotypes.66 Breakpoints in nonrecurrent trans-
locations and marker chromosomes have been frequently
mapped at the centromere.11–14 By array CGH, we mapped
duplication breakpoints in the 13 subjects with uncom-
mon duplications. Remarkably, 7 of 10 simple duplica-
tions have proximal breakpoints mapping to the centro-
mere or the pericentromeric region. In contrast, none of
the uncommon deletion breakpoints ( ) are locatednp 18
within or close to the centromere. This difference is sta-
tistically significant ( ) by Fisher’s exact test. In-Pp .002
terestingly, three of the breakpoints in this 17p breakpoint
grouping are at the gap at 21.5 Mb that is among the nine
euchromatic gaps in chromosome 17.43 It is one of only
two gaps that are apparently refractory to cloning and are
associated with primate-specific breaks in conserved syn-
teny. This gap at 21.5 Mb is flanked by AT-rich genomic
sequence; fosmid XXfos-82794E5 mapping distal to the
gap has a 57% AT content, and XXfos-82794E5 mapping
proximal to the gap has a 66% AT content. Regions of
several hundred kilobases flanking this gap are enriched
with both interchromosomal and intrachromosomal seg-
mental duplications according to the Segmental Dupli-
cation Database. The complete sequence of BAC RP11-
822E23 shares 92%–96% homology with 10–100-kb
segments from chromosomes 2, 4, 7, 8, and 17. Further
genome architectural complexity includes a 30-kb frag-
ment in this BAC that was found in an inverted orien-
tation with 97% homology to BAC RP11-1109M24, a
clone that maps to the proximal side of the gap that is
∼450 kb from the centromeric heterochromatin. Two
structural variations (variations _0497 and _0498) are pre-
sent in the BAC proximally adjacent to RP11-1109M24
(Database of Genomic Variants Human Genome Assembly
build 36). A recent CNV map of the human genome40
showed that the chromosome 17p pericentromeric region
is a highly variable CNV region. This 17p pericentromeric
region also appears to manifest genomic instability in so-
matic cells.67 In addition, whereas, for the uncommon du-
plications with proximal breakpoints close to the centro-
mere, five of six cases studied resulted from maternal
intrachromosomal recombination, 12 of the 14 uncom-
mon deletions were of paternal origin.11
Given these data, we propose that the mechanism re-
sponsible for proximal 17p duplication may be different
from that involved in 17p deletion. An instability factor
for duplication occurrence appears to be related to the
specific structure and organization at or near the centro-
mere. Pericentromeric regions provide boundaries be-
tween the heterochromatic centromeric alpha satellite
and the unique euchromatic gene-containing sequences.
In the short arm of chromosome 17, the pericentromeric
region shows extensive zones of segmental duplication
ranging from 500 kb to 5.5 Mb.68 Our data indicate that
LCRs near the centromere stimulate nonrecurrent dupli-
cations. Pericentromeric and centromeric regions are also
the frequent breakpoints for translocations11 and marker
chromosomes12–14 involving proximal 17p. Several break-
points of translocations were also located within LCRs,11
indicating that segmental duplications may play a role in
these genomic rearrangements as well as during evolution.
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Our breakpoint analysis of proximal 17p duplications pro-
vide further evidence to support the concept that genomic
architecture plays an important role in genome instability.
Grouping of duplication breakpoints in specific regions
has also been observed recently in a study of the dupli-
cation rearrangements associated with Pelizaeus-Merz-
bacher disease, a genomic disorder most commonly
caused by genomic duplications of the proteolipid protein
gene (PLP1 [MIM 300401]).69 PLP1 duplications are dif-
ferent in size and do not cluster to a specific set of LCRs.
Breakpoint mapping in patients with multiple duplication
showed that most of the breakpoints appear to be in prox-
imity to segmental duplications.70 Nucleotide sequence of
recombinant junction reveals that both duplications71 and
deletions72 involving PLP1 appear to occur by nonhom-
ologous end joining and not by NAHR. The PLP1 dupli-
cation studies and our breakpoint analyses of dup17p11.2
suggest that genomic structure stimulates but does not
mediate these nonrecurrent duplication events.
In summary, we phenotypically characterized PLS
(dup(17)(p11.2p11.2) syndrome), narrowed the critical re-
gion to a 1.3-Mb interval, further documented LCR in-
volvement in duplication rearrangements, again dem-
onstrated NAHR as the predominant recombination
mechanism, provided evidence in support of the hypoth-
esis that RAI1 is the dosage-sensitive gene causing this
syndrome, and objectively defined a dosage-sensitive lo-
cus conferring an autism phenotype that maps within the
critical interval for PLS.
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